致病性肥胖症和肝移植
Gerardo Moro1, Arkaitz Perfecto2, Jaime Encinas1
1BioBizkaia Research Health Institute. Barakaldo, Bizkaia, Spain.
Transplantation proceedings
|January 8, 2025
概括
致病性肥胖症 (MO) 不适用于肝移植 (LT). 接受LT的MO患者表现出令人满意的结果,患者和移植者5年生存率为97%,这表明MO不应该是禁忌.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 减肥医学 减肥医学
背景情况:
- 致病性肥胖 (MO) 的患病率上升影响了各种患者群体.
- 在符合肝移植 (LT) 资格的肝病患者中,越来越多地观察到MO.
研究的目的:
- 评估致病性肥胖对肝移植后发病率,死亡率和生存率的影响.
- 确定MO是否应该被认为是LT的禁忌.
主要方法:
- 一个单一中心的患者队列的回顾性分析 MO 接受 LT.
- 收集的数据包括身体质量指数 (BMI),LT的征兆,术后并发症和生存率.
主要成果:
- 在2004年至2023年期间,15名BMI≥40kg/m2的患者接受了LT.
- 常见的症状包括肝硬化 (93%);5名患者出现严重并发症.
- 五年患者和移植的存活率高达97%.
结论:
- 在患有病态肥胖症的患者中,肝移植带来了令人满意的术后结果和生存率.
- 致病性肥胖症不应被认为是肝移植的绝对禁忌.
相关概念视频
01:24Obesity
372
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
372
01:24Tissue Transplantation
337
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
337